Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death - The trans-European network-home-care management system (TEN-HMS) study

被引:509
作者
Cleland, JGF
Louis, AA
Rigby, AS
Janssens, U
Balk, AHMM
机构
[1] Univ Hull, Kingston Upon Hull, Yorks, England
[2] Univ Klinikum Aachen, Aachen, Germany
[3] Erasmus MC, Ctr Thorax, Rotterdam, Netherlands
关键词
D O I
10.1016/j.jacc.2005.01.050
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We sought to identify whether home telemonitoring (HTM) improves outcomes compared with nurse telephone support (NTS) and usual care (UC) for patients with heart failure who are at high risk of hospitalization or death. BACKGROUND Heart failure is associated with a high rate of hospitalization and poor prognosis. Telemonitoring could help implement and maintain effective therapy and detect worsening heart failure and its cause promptly to prevent medical crises. METHODS Patients with a recent admission for heart failure and left ventricular ejection fraction (LVEF) < 40% were assigned randomly to HTM, NTS, or UC in a 2:2:1 ratio. HTM consisted of twice-daily patient self-measurement of weight, blood pressure, heart rate, and rhythm with automated devices linked to a cardiology center. The NTS consisted of specialist nurses who were available to patients by telephone. Primary care physicians delivered UC. The primary end point was days dead or hospitalized with NTS versus HTM at 240 days. RESULTS Of 426 patients randomly assigned, 48% were aged > 70 years, mean LVEF was 25% (SD, 8) and median plasma N-terminal pro-brain natriuretic peptide was 3,070 pg/ml (interquartile range 1,285 to 6,749 pg/ml). During 240 days of follow-up, 19.5%, 15.9%, and 12.7% of days were lost as the result of death or hospitalization for UC, NTS, and HTM, respectively (no significant difference). The number of admissions and mortality were similar among patients randomly assigned to NTS or HTM, but the mean duration of admissions was reduced by 6 days (95% confidence interval 1 to 11) with HTM. Patients randomly assigned to receive UC had higher one-year mortality (45%) than patients assigned to receive NTS (27%) or HTM (29%) (p = 0.032). CONCLUSIONS Further investigation and refinement of the application of HTM are warranted because it may be a valuable role for the management of selected patients with heart failure. (c) 2005 by the American College of Cardiology Foundation.
引用
收藏
页码:1654 / 1664
页数:11
相关论文
共 18 条
  • [1] Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure - Too many cooks will spoil the broth
    Cleland, JGF
    Clark, AL
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (07) : 1234 - 1237
  • [2] Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey
    Cleland, JGF
    Cohen-Solal, A
    Aguilar, JC
    Dietz, R
    Eastaugh, J
    Follath, F
    Freemantle, N
    Gavazzi, A
    van Gilst, WH
    Hobbs, FDR
    Korewicki, J
    Madeira, HC
    Preda, I
    Swedberg, K
    Widimsky, J
    [J]. LANCET, 2002, 360 (9346) : 1631 - 1639
  • [3] How to assess new treatments for the management of heart failure: composite scoring systems to assess the patients' clinical journey
    Cleland, JGF
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) : 243 - 247
  • [4] The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis
    Cleland, JGF
    Swedberg, K
    Follath, F
    Komajda, M
    Cohen-Solal, A
    Aguilar, JC
    Dietz, R
    Gavazzi, A
    Hobbs, R
    Korewicki, J
    Madeira, HC
    Moiseyev, VS
    Preda, I
    van Gilst, WH
    Widimsky, J
    Freemantle, N
    Eastaugh, J
    Mason, J
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (05) : 442 - 463
  • [5] Is the prognosis of heart failure improving?
    Cleland, JGF
    Gemmell, I
    Khand, A
    Boddy, A
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 1999, 1 (03) : 229 - 241
  • [6] Corell P, 2004, EUR HEART J, V25, P60
  • [7] Risk stratification in chronic heart failure
    Cowburn, PJ
    Cleland, JGF
    Coats, AJS
    Komajda, M
    [J]. EUROPEAN HEART JOURNAL, 1998, 19 (05) : 696 - 710
  • [8] Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure
    Galbreath, AD
    Krasuski, RA
    Smith, B
    Stajduhar, KC
    Kwan, MD
    Ellis, R
    Freeman, GL
    [J]. CIRCULATION, 2004, 110 (23) : 3518 - 3526
  • [9] Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: The Weight Monitoring in Heart Failure (WHARF) trial
    Goldberg, LR
    Piette, JD
    Walsh, MN
    Frank, TA
    Jaski, BE
    Smith, AL
    Rodriguez, R
    Mancini, DM
    Hopton, LA
    Orav, EJ
    Loh, E
    [J]. AMERICAN HEART JOURNAL, 2003, 146 (04) : 705 - 712
  • [10] Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure - A substudy of the carvedilol prospective randomized cumulative survival (COPERNICUS) trial
    Hartmann, F
    Packer, M
    Coats, AJS
    Fowler, MB
    Krum, H
    Mohacsi, P
    Rouleau, JL
    Tendera, M
    Castaigne, A
    Anker, SD
    Amann-Zalan, I
    Hoersch, S
    Katus, HA
    [J]. CIRCULATION, 2004, 110 (13) : 1780 - 1786